Work

A phase II study of dual immune checkpoint blockade (ICB) plus androgen receptor (AR) blockade to enhance thymic T-cell production and immunotherapy response in metastatic breast cancer (MBC).

Year: 2019

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2019.37.15_suppl.tps1106

Authors: David B. Page, Isaac K Kim, Brie Chun, William L Redmond, Maritza Martel, Motomi Mori, Dottie Wadell, Nicole Moxon, Staci L. Mellinger, Walter John Urba, Ayca Gucalp, Tiffany A. Traina

Institutions: OHSU Knight Cancer Institute, Providence Portland Medical Center, Memorial Sloan Kettering Cancer Center

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2947041055

Cites:

Cited by: 6

Related to: 10